[1] |
YOUNG SG. Recent progress in understanding apolipoprotein B[J]. Circulation, 1990, 82(5): 1574-1594. DOI: 10.1161/01.cir.82.5.1574.
|
[2] |
MEHTA A, SHAPIRO MD. Apolipoproteins in vascular biology and atherosclerotic disease[J]. Nat Rev Cardiol, 2022, 19(3): 168-179. DOI: 10.1038/s41569-021-00613-5.
|
[3] |
BURNETT JR, BELL DA, HOOPER AJ, et al. Clinical utility gene card for: Familial hypobetalipoproteinaemia (APOB)[J]. Eur J Hum Genet, 2012, 20(8): e1-e3. DOI: 10.1038/ejhg.2012.85.
|
[4] |
TANOLI T, YUE P, YABLONSKIY D, et al. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity[J]. J Lipid Res, 2004, 45(5): 941-947. DOI: 10.1194/jlr.M300508-JLR200.
|
[5] |
OHASHI K, ISHIBASHI S, OSUGA J, et al. Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia[J]. J Lipid Res, 2000, 41(8): 1199-1204.
|
[6] |
TAKAHASHI M, OKAZAKI H, OHASHI K, et al. Current diagnosis and management of abetalipoproteinemia[J]. J Atheroscler Thromb, 2021, 28(10): 1009-1019. DOI: 10.5551/jat.RV17056.
|
[7] |
SIRWI A, HUSSAIN MM. Lipid transfer proteins in the assembly of apoB-containing lipoproteins[J]. J Lipid Res, 2018, 59(7): 1094-1102. DOI: 10.1194/jlr.R083451.
|
[8] |
WELTY FK. Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease[J]. Curr Opin Lipidol, 2020, 31(2): 49-55. DOI: 10.1097/MOL.0000000000000663.
|
[9] |
COHEN JC, BOERWINKLE E, MOSLEY TH Jr, et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease[J]. N Engl J Med, 2006, 354(12): 1264-1272. DOI: 10.1056/NEJMoa054013.
|
[10] |
TARUGI P, LONARDO A. Heterozygous familial hypobetalipoproteinemia associated with fatty liver[J]. Am J Gastroenterol, 1997, 92(8): 1400-1402.
|
[11] |
WELTY FK. Hypobetalipoproteinemia and abetalipoproteinemia[J]. Curr Opin Lipidol, 2014, 25(3): 161-168. DOI: 10.1097/MOL.0000000000000072.
|
[12] |
BURNETT JR, HOOPER AJ. Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia[J]. Free Radic Biol Med, 2015, 88(Pt A): 59-62. DOI: 10.1016/j.freeradbiomed.2015.05.044.
|
[13] |
LEE J, HEGELE RA. Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management[J]. J Inherit Metab Dis, 2014, 37(3): 333-339. DOI: 10.1007/s10545-013-9665-4.
|
[14] |
BREDEFELD C, PERETTI N, HUSSAIN MM, et al. New classification and management of abetalipoproteinemia and related disorders[J]. Gastroenterology, 2021, 160(6): 1912-1916. DOI: 10.1053/j.gastro.2020.11.040.
|